IP Verse

Process For Concentration Of Antibodies And Therapeutic Products Thereof

EP4108259

GENENTECH, INC.
Application Number
EP22178117A
Filing Date
Sep 8, 2005
Status
Granted And Under Opposition
Dec 1, 2023
Grant Date
Jan 3, 2024
External Links
Slate, Register

Biblio Summary

The patent EP4108259B1 was granted on Jan 3, 2024 by Genentech, Inc. The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CELLTRION INC.Oct 4, 2024ADMISSIBLE

More Opposed Patents of Genentech, Inc.

The table below shows the patents of Genentech, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2694072Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of UseAug 7, 20241
EP3589661Adjuvant Treatment Of Her2-Positive Breast CancerNov 1, 20234
EP2784084Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofOct 4, 20235

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents